Developing and evaluating in preclinical studies a new vaccine based on mRNA against SARS-CoV2 capable of inducing long-term immune responses against the virus is the ultimate goal of the research project in which the laboratory led by María José Alonso participates together with the group led by Mabel Loza, both at CiMUS and FIDIS – University of Santiago de Compostela (USC). The objective of the USC laboratories is to produce a synthetic vehicle based on innocuous biomaterials, capable of transporting the mRNA into the target cells and enabling the production of the antigen in the human body.
The project has obtained funding from the Health Department of the Generalitat de Catalunya and the Carlos III Health Institute (ISCIII)… Continue reading.
WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending induction of Maria Jose Alonso, Ph.D., Professor, Dept. Pharmacology, Pharmacy And Pharmaceutical Technology, Cimus Research Center, University of Santiago De Compostela, to its College of Fellows. Dr. Alonso was nominated, reviewed, and elected by peers and members of the College of Fellows For outstanding contributions to the field of drug delivery, pioneering the design of nanomaterials that help drugs overcoming biological barriers..